Funding Entity: Nanoimmunotech S.L.
Principal Investigator: Dr. África González-Fernández
Duration: 03/04/2017 – 30/06/2018
The objective of the project is to validate the use of biodegradable nanoparticles of lipid, polymeric or chitosan-based origin, to encapsulate different antibiotics and enhance their effect by increasing the half-life of the drug, as well as reducing its systemic toxicity. This would allow reducing the dose and / or periodicity, as well as the possibility of concentrating the effect on the damaged tissue.
Associated research lines: Nanomedicine.